|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prehypertension in disease-free adults:a marker for an adverse cardiometabolic risk profile显示文摘 | Gupta AK McGlone M Greenway FL | 2010 | Hypertens Res2010，33，9： | 1 |
| 2 | Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I):a multicentre,randomised,double-blind,placebo-controlled,phase 3 trial显示文摘 | Greenway FL Fujioka K Plodkowski RA | | 0，，： | 1 |
| 3 | The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent显示文摘 | Greenway FL | 2001 | Obes Rev2001，2，3： | 1 |
| 4 | Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-1) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 显示文摘 | Greenway FL Fujioka K Plodkowski RA | 2010 | Lan- cet2010，376，9741： | 1 |
| 5 | Current and potential drugs for treatment of obesity显示文摘 | Bray GA Greenway FL | 1999 | Endocr Rev1999，20，6： | 1 |
| 6 | Effects of obesity surgery on non-insulin-dependent diabetes mellitus显示文摘 | Greenway SE Greenway FL Klein S | 2002 | Arch Surg2002，137，10： | 1 |
| 7 | Comparison of methods to assess body composition changes during a period of weight loss 显示文摘 | Frisard MI Greenway FL Delany JP | 2005 | Obes Res2005，13，5： | 1 |
| 8 | Bupro-pion SR enhances weight loss: a 48-week doubleblind, placebo-controlled trial显示文摘 | ANDERSON JW GREENWAY FL FUJIOKA al | 2002 | Obes Res2002，10，7： | 1 |
| 9 | Rational design of a combination medication for the treatment ofobesity显示文摘 | GREENWAY FL WHITEHOUSE MJ GUTTADAURIA M | 2009 | Obesity (Silver Spring)2009，17，1： | 1 |
| 10 | Effects of obesity surgery on non-insulin-dependent diabetes mellitus 显示文摘 | Grecnway SE Greenway FL Klein S | 2002 | Arch Surg2002，137，10： | 1 |
| 11 | Prehyperten- sion in disease-free adults: a marker for an adverse cardiometabolic risk profile 显示文摘 | Gupta AK McGlone M Greenway FL | 2010 | Hypertens Res2010，33，9： | 1 |
| 12 | Pharmacological ~eatment of the overweight patient显示文摘 | Bray GA Greenway FL | 2007 | Pharmacol Rev2007，59，： | 1 |
| 13 | Effects of obesity surgery on non-insulin-dependent diabetes mellitus显示文摘 | Greenway SE Greenway FL 3rd Klein S | 2002 | Arch Surg2002，137，10： | 1 |
| 14 | Bupropion SR significantly enhances weight loss : a 24 - week double - blind, placebo - controlled trial with placebo group randomized to bupropion SR during 24 - week extension 显示文摘 | Anderson JW Greenway FL Fujioka K | 2002 | Obes Res2002，10，： | 1 |
| 15 | Safety of obesity drugs显示文摘 | Greenway FL Caruso MK | 2005 | Expert Opin Drug Safety2005，4，6： | 1 |
| 16 | Current and potential drugs for treatment of obesity 显示文摘 | Bray GA Greenway FL | 1999 | Endocr Rev1999，20，6： | 1 |
| 17 | Combination drugs for treating obesity显示文摘 | Greenway FL Bray GA | 2010 | Curr Diab Rep2010，10，2： | 1 |
| 18 | Effects of obesity surgery on non-insulin-dependent diabetes mellitus 显示文摘 | Greenway SE Greenway FL 3rd Klein S | 2002 | Arch Surg2002，137，10： | 1 |
| 19 | Effect of naltrexone plus bupropion on weight loss in overweight and obese adults(COR-I):A multicentre,randomised,double-blind,placebo-controlled,phase 3 trial显示文摘 | Greenway FL Fujioka K Plodkowski RA | 2010 | Lancet2010，376，9741： | 1 |
| 20 | Effects of obesity surgery on non - insulin - dependent diabetes mcllitus显示文摘 | Greenway SE Greenway FL Klein S | 2002 | Arch Surg2002，137，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员